• MenQuadfi Vaccine

    The European Commission (EC) has approved MenQuadfi  immunization of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria Meningitidis serogroups A, C, W and Y. Invasive meningococcal disease (IMD) epidemiology has been a challenge because it is highly unpredictable and varies widely with different countries leaving room for […]

    Continue reading